EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Narrative Review for the Use of Kampo Medicine During Pregnancy in Japan

Ryutaro Arita, Taku Obara, Aoi Noda, Satoko Suzuki, Ken Haneda, Minoru Ohsawa, Hiromi Yoshida‐Komiya, Akiko Kikuchi, Shin Takayama, Tadashi Ishii

Traditional & Kampo Medicine · 2026-04 · 13 (1)

DOI: 10.1002/tkm2.70044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Traditional & Kampo Medicine, online erschienen am 10.03.2026. Verfasst von Ryutaro Arita und 9 weiteren Autor:innen. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kampo medicine is commonly prescribed alongside Western pharmaceuticals. Its use during pregnancy has become increasingly common; however, there are concerns regarding safety due to the inclusion of multiple herbal components.

Objective

We aim to summarize the current evidence on the use and safety of Kampo medicines during pregnancy in Japan.

Methods

A comprehensive literature review was conducted using nine key studies, including claims database analyses and large birth cohort investigations. These were divided into two main categories: (1) studies describing the prevalence and patterns of Kampo medicine use during pregnancy, and (2) studies investigating safety outcomes such as congenital malformation, birth weight, preterm birth, hospitalization, and live birth rates.

Results

The proportion of pregnant women using Kampo medicines ranges from 4% to 10%, with common formulations including tokishakuyakusan, shoseiryuto, and kakkonto. Studies from both claims databases and cohort‐based self‐reports confirm widespread use. Regarding safety, multiple observational studies report no significant increase in congenital malformations, low birth weight, or preterm birth associated with Kampo medicine use. Some studies even suggest beneficial effects, such as reduced hospitalization for hyperemesis and increased live birth rates in women with recurrent pregnancy loss. However, caution is warranted for Kampo formulations containing potentially teratogenic substances such as ephedra and rhubarb.

Conclusion

Kampo medicine is widely used among pregnant women in Japan and appears to have a generally favorable safety profile when prescribed appropriately. Nonetheless, more rigorous prospective studies are needed to confirm safety across various Kampo formulations and patient populations.

Förderung

  • Ministry of Health, Labour and Welfare
  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development

Zitieren

APA

Arita, R., Obara, T., Noda, A., Suzuki, S., Haneda, K., Ohsawa, M., Yoshida‐Komiya, H., Kikuchi, A., Takayama, S., & Ishii, T. (2026). Narrative Review for the Use of Kampo Medicine During Pregnancy in Japan. Traditional & Kampo Medicine, 13(1). https://doi.org/10.1002/tkm2.70044

Vancouver

Arita R, Obara T, Noda A, Suzuki S, Haneda K, Ohsawa M, et al. Narrative Review for the Use of Kampo Medicine During Pregnancy in Japan. Traditional & Kampo Medicine. 2026;13(1). doi:10.1002/tkm2.70044

BibTeX
@article{Arita2026,
  author = {Arita, Ryutaro and Obara, Taku and Noda, Aoi and Suzuki, Satoko and Haneda, Ken and Ohsawa, Minoru and Yoshida‐Komiya, Hiromi and Kikuchi, Akiko and Takayama, Shin and Ishii, Tadashi},
  title = {Narrative Review for the Use of Kampo Medicine During Pregnancy in Japan},
  journal = {Traditional & Kampo Medicine},
  year = {2026},
  volume = {13},
  number = {1},
  doi = {10.1002/tkm2.70044}
}
Kostenlos starten →